Translational Drug Abuse Prevention (TDAP)

OSLC, in collaboration with the University of Oregon and the University of Southern California, received a $9 Million grant from National Institute on Drug Abuse to launch the Translational Drug Abuse Prevention (TDAP) Center. The grant was one of the largest ever received by OSLC. The project, led by scientists Dr. Patricia Chamberlain and Dr. Phil Fisher, included a group of multidisciplinary scientists from OSLC and its partner organizations, who collaborated to create a national resource for cutting-edge, innovative research with studies spanning from basic science to implementation research in U.S. child welfare systems. Children and adolescents involved in child welfare are among the most disadvantaged individuals in American society and are at greatly elevated risk for drug use and related problems including delinquency, teen pregnancy, poor physical and mental health, homelessness, incarceration, and HIV-risk behaviors. Moreover, long-term follow up studies show that even with existing community-based services, for many children involved in child welfare these problems prove intractable into adulthood. The TDAP Center focused on broadening our understanding of underlying mechanisms that contribute to healthy development and testing practical interventions and implementation strategies to improve outcomes for children and families involved in U.S. child welfare systems.

Year Project Began: 2013
Funder: National Institute on Drug Abuse

Principal Investigator:

• Patricia Chamberlain, Ph.D.

Co-Investigators:

• Rohanna Buchanan, Ph.D.
• Katherine C. Pears, Ph.D.
• Philip Fisher, Ph.D.

Formerly Affiliated Co-Investigators:

• Jason E. Chapman, Ph.D.
• Lisa Saldana, Ph.D.